No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

7 Patient Recruitment and Retention Tips for a Clinical Trial

Editor: What To Know

  • When choosing a clinical trial recruitment company, you want to choose one with a particular specialty in a patient population or therapeutic area.
  • You may also be interested in finding a clinical trial company like H Clinical that provides additional services like helping you find the best location for your study or developing your pre-screener.
  • According to a report by the National Institute of Cancer, most clinical trials have either been abandoned or delayed due to a low number of subjects.

The invention of new treatment methods and drugs depends on the ability to test and validate the research. In recent years, it has not been easy for organizations to conduct clinical trials. One area that has been notoriously difficult is the recruitment and retention of patients.

According to a report by the National Institute of Cancer, most clinical trials have either been abandoned or delayed due to a low number of subjects. The report showed that only 6% of clinical trials are completed on time. In this article, we have put together creative clinical trial recruitment strategies that will help you attract and retain patients.

1.   Work with the right clinical trial recruitment company

When choosing a clinical trial recruitment company, you want to choose one with a particular specialty in a patient population or therapeutic area. You may also be interested in finding a clinical trial company like H Clinical that provides additional services like helping you find the best location for your study or developing your pre-screener.

2.   Improve patient screening methods

Once patients have been identified, there should be an effective screening process that requires little travel and is minimally invasive. Thanks to technologies like random sampling, these processes are now possible. They allow candidates to submit their samples from wherever they are without the need to visit the research facility.

3.   Make the process patient-centric

Your patient recruitment process should be based on individual patients and not diseases. The study design should include the patients’ voices to ensure the clinical trial has meaningful endpoints to patients. If a clinical trial doesn’t meet real patient needs, it makes recruitment even more difficult. To make the procurement process patient-centered:

  • Get their feedback about the study design
  • Engage the community, patients, and their peers as volunteers in the clinical trial
  • Provide feedback about clinical results
4.   Provide financial incentives for patients

Although offering financial incentives in healthcare can be controversial, giving modest reimbursement for the patient’s trouble can enhance the recruitment and retention of patients.

5.   Utilize interactive aids to boost enrolment

Lack of relevant information is a major reason why people shun clinical trials. How you deliver information to patients can have a great impact on the enrolment rate. Videos and audiovisual materials are more effective in encouraging enrolment compared to written materials.

6.   Use social media and mobile platforms

Two decades ago, patients learned about clinical trials through their health care providers, mail, or media, but this has changed. Thanks to smartphones and social media, communication is much more direct today. Social media platforms like Facebook and Twitter have made it quite easy to recruit patients for clinical trials.

7.   Create systems to track and follow up with patients

When the patients have enrolled in the trial, the focus now shifts to retaining them. Use automated text messages or emails to remind patients to take the next step. You can also monitor their response to drugs remotely using microsampling devices.

Endnote

Recruiting patients for clinical trials is a major challenge for modern science. Clarifying myths, providing accurate information, and incentivizing volunteers are effective ways to encourage enrolment in clinical trials.

 

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy